ClinicalTrials.gov
public full text
Public Domain
Biomarkers In Seizure To Predict Recurrence and Severe Outcomes
We study the hypothesis that combination of Proteine S100 beta and Copeptin within normal ranges can rule out seizure recurrences and severe outcome, and allow early discharge from the emergency department
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- S100B Protein: a Diagnostic Aid in Episodes of Transient Loss of Consciousness?#1137793
- Comparing Injury Volume and Epilepsy Outcomes for Traumatic Brain Injury (TBI) Patients#989837
- Efficacy Study of Intravenous Sodium Valproate in Addition to First Line Anti Epileptic Treatment of Generalized Convulsive Status Epilepticus.#913125
- EEG Biomarkers of Epileptogenesis#2163
- Association between p-tau181 in cerebrospinal fluid and shunt response in patients with normal-pressure hydrocephalus#784535
Record · ID 907709
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive